George Jessica Anne, Kost-Byerly Sabine, Monitto Constance L
Assistant Professor, Division of Pediatric Anesthesiology, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institution, Baltimore, Maryland.
Associate Professor, Division of Pediatric Anesthesiology, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institution, Baltimore, Maryland.
J Opioid Manag. 2013 Sep-Oct;9(5):357-68. doi: 10.5055/jom.2013.0178.
After conducting a thorough literature search of adolescent opioid use from 1990 until present, it became readily apparent that the last decade has witnessed an increase in the number of opioid-related drug overdoses and deaths in the adolescent population, analogous to the epidemic in the adult population. Most of these cases have resulted from prescription medication misuse. Practitioners who use controlled substances to treat pain in pediatric and adolescent patients want to limit harm by carefully assessing their patients' risk of abuse and diversion. In this article, the authors present current knowledge and recommendations for the mitigation of aberrant prescription drug use in the pediatric population.
在对1990年至今的青少年阿片类药物使用情况进行全面的文献检索后，很明显，过去十年中，青少年群体中与阿片类药物相关的药物过量使用和死亡人数有所增加，这与成年人群体中的疫情类似。这些病例大多是由处方药滥用导致的。使用受控物质治疗儿科和青少年患者疼痛的从业者希望通过仔细评估患者的滥用和转移风险来减少伤害。在本文中，作者介绍了减轻儿科人群异常处方药使用的现有知识和建议。
